in Clinical Practice of a Multifactorial Intervention for the Reduction of Cardiovascular Risk in Patients With Type 2 Diabetes The 2-year interim analysis of the MIND.IT study: a cluster randomized trial
暂无分享,去创建一个
M. Boemi | D. Ardigò | M. Trovati | G. Reboldi | I. Zavaroni | O. Vaccaro | A. Rivellese | P. Feo | R. Miccoli | F. Cavalot | L. Franzini
[1] D. Ardigò,et al. Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[2] K Khunti,et al. Intensive multifactorial intervention improves modelled coronary heart disease risk in screen‐detected Type 2 diabetes mellitus: a cluster randomized controlled trial , 2012, Diabetic medicine : a journal of the British Diabetic Association.
[3] Kamlesh Khunti,et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial , 2011, The Lancet.
[4] G. Mancia,et al. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients , 2011, Journal of hypertension.
[5] Eliseo Guallar,et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study , 2011, European heart journal.
[6] C. J. Bailey,et al. Patient adherence to medication requirements for therapy of type 2 diabetes , 2011, International journal of clinical practice.
[7] Dirk De Bacquer,et al. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[8] A. Nicolucci,et al. Four‐year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics: the AMD‐Annals initiative , 2010, Diabetic medicine : a journal of the British Diabetic Association.
[9] R. Lyons,et al. Population based absolute and relative survival to 1 year of people with diabetes following a myocardial infarction: A cohort study using hospital admissions data , 2010, BMC public health.
[10] N. Sattar,et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials , 2009, The Lancet.
[11] W. Stewart,et al. Factors Associated with First-Fill Adherence Rates for Diabetic Medications: A Cohort Study , 2009, Journal of general internal medicine.
[12] M. Boemi,et al. The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy. , 2008, Atherosclerosis.
[13] O. Pedersen,et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.
[14] M. Engelgau,et al. Improvements in Diabetes Processes of Care and Intermediate Outcomes: United States, 19882002 , 2006, Annals of Internal Medicine.
[15] Jay R. Desai,et al. Randomized trial of quality improvement intervention to improve diabetes care in primary care settings. , 2005, Diabetes care.
[16] Jonathan L. Blitstein,et al. Design and analysis of group-randomized trials: a review of recent methodological developments. , 2004, American journal of public health.
[17] S. Kaplan,et al. Role of organizational factors in poor blood pressure control in patients with type 2 diabetes: the QuED Study Group--quality of care and outcomes in type 2 diabetes. , 2003, Archives of internal medicine.
[18] Oluf Pedersen,et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.
[19] Sid,et al. [Guidelines for cardiovascular prevention in diabetic patients]. , 2002, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[20] Allan Donner,et al. Design and Analysis of Cluster Randomization Trials in Health Research , 2001 .
[21] R. Holman,et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. , 1999, JAMA.